Nonetheless, we suggest that salivary levels of t-tau and NfL could serve as non-invasive biomarkers, representing early (PM) and later (manifest HD) stages of illness, respectively, and provide new information regarding the development and disease progression HD. This evidence concerns the gene NEFL and Huntington disease.